Centauri Therapeutics is based in London, England. It has raised $38M in total funding. Latest round: Series A.
Centauri Therapeutics is based in London, England. Centauri Therapeutics has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2022. The round record for Centauri Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Boehringer Ingelheim Venture Fund, Evotec SE, Novo Holdings REPAIR Impact Fund, AMR Action Fund. 4 distinct backers are named across the disclosed rounds.
Centauri Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in London below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026